Cannabis producer Bedrocan is going to commercialize a new cannabis variety with a cannabidiol (CBD) content of 14 percent. With this, the company is responding to increasing demand for medicinal cannabis with high CBD content. The new variety will be produced primarily at the new facility in Denmark.
CEO Jaap Erkelens reveals: "The new CBD variety will be available under the brand name Bedrolina."
The brand-new production facility in Denmark will be operational in Q1, 2025.
Erkelens about this project: "The construction took about a year and a half, but we got exactly what we wanted. Everything was set up according to Bedrocan's method so we can also supply standardised medicinal cannabis from this facility."
Bedrocan also plans to grow Bedrolina on a large scale outdoors. This is unique because Bedrocan currently only grows indoors. With the outdoor biomass, Bedrocan is targeting primarily the cosmetics industry. The demand for CBD has grown substantially, partially due to the inclusion of naturally-derived cannabidiol in the Cosing (Common cosmetic ingredient ) database that lists all substances authorized in cosmetics.
For more information:
Bedrocan
www.bedrocan.com